IP Library Granted Patent US 10,939,911
Granted Patent B2
US 10,939,911 · App. 15/621,551 · Granted Mar 9, 2021

Surgical stapler with end effector coating

Inventors: Thomas W. Huitema (Cincinnati, OH); Xintian Ming (Bridgewater, NJ); Tamara S. Widenhouse (Clarksville, OH); Frederick E. Shelton, IV (Hillsboro, OH)
Assignee: Ethicon LLC
A61B17/07292A61B17/0644A61B17/072A61B17/07207A61L31/06A61L31/10A61L31/14A61L31/16A61B17/064A61B17/1155A61B2017/00004A61B2017/00464A61B2017/00477A61B2017/00526A61B2017/00884A61B2017/00893A61B2017/07257A61B2017/07271A61B2017/07278A61B2017/07285A61L2420/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,939,911
App. No.
15/621,551
Granted
Mar 9, 2021
Kind
B2
Abstract

Methods and devices are provided for promoting wound healing. In general, surgical staplers and stapler components are provided having a coating thereon that is configured to selectively control an interaction between at least one matrix metalloproteinase (MMP) inhibitor and an outer surface of the stapler or stapler component.

Claims (20)

1. A staple cartridge assembly for use with a surgical stapler, comprising:

a cartridge body having

a plurality of staple cavities,

a plurality of staples, each staple being disposed within one of the plurality of staple cavities,

a plurality of staple drivers, the plurality of staple drivers being upwardly movable to eject the plurality of staples from the plurality of staple cavities, and

a sled longitudinally movable through the cartridge body and configured to cause upward movement of the plurality of staple drivers;

wherein at least a first portion of an outer surface of at least one of the cartridge body, the plurality of staple cavities, the plurality of staples, and the plurality of staple drivers includes an adhesion coating configured to permit adhesion of at least one matrix metalloproteinase (MMP) inhibitor to the at least a first portion of the outer surface; and

wherein at least a second portion of an outer surface of at least one of the cartridge body, the plurality of staple cavities, the plurality of staples, and the plurality of staple drivers includes an anti-adhesion coating configured to minimize adhesion of the at least one MMP inhibitor to the at least a second portion of the outer surface.

2. The assembly of claim 1 , wherein the adhesion coating is disposed on the at least a first portion of the outer surface of the plurality of staples, and the anti-adhesion coating is disposed on the at least a second portion of the outer surface of at least one of the cartridge body, the plurality of staple drivers, and the sled.

3. The assembly of claim 1 , wherein the adhesion coating is disposed on the at least a first portion of the outer surface of the plurality of staples.

4. The assembly of claim 1 , wherein the anti-adhesion coating is disposed on the at least a first portion of the outer surface of at least one of the cartridge body, the plurality of staple drivers, and the sled, and wherein the anti-adhesion coating comprises at least one masking agent.

5. The assembly of claim 4 , wherein the at least one masking agent is selected from the group consisting of a lubricant, parlyene, and combinations thereof.

6. The assembly of claim 5 , wherein the lubricant comprises silicone.

7. The assembly of claim 1 , wherein the adhesion coating is disposed on the at least a first portion of the outer surface of the plurality of staples, and wherein the coating comprises an absorbable substance.

8. The assembly of claim 7 , wherein the absorbable substance is selected from the group consisting of an absorbable polymer and an absorbable lubricant.

9. The assembly of claim 8 , wherein the absorbable polymer comprises polyurethane.

10. The assembly of claim 8 , wherein the absorbable polymer is polymerized in the presence of the at least one MMP inhibitor, thereby resulting in an absorbable polymer/MMP inhibitor blend.

11. The assembly of claim 7 , wherein the absorbable substance is water soluble.

12. The assembly of claim 7 , wherein the absorbable substance is ionically charged.

13. The assembly of claim 1 , wherein the adhesion coating is disposed on the at least a first portion of the outer surface of the plurality of staples, and wherein the anti-adhesion coating is disposed on the at least a second portion of the outer surface of the plurality of staples.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2021
From: ETHICON LLC
To: CILAG GMBH INTERNATIONAL
Reel/Frame 056601/0339 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2017
From: HUITEMA, THOMAS W.; MING, XINTIAN; WIDENHOUSE, TAMARA S.; SHELTON, FREDERICK E., IV
To: ETHICON LLC
Reel/Frame 044005/0203 →
Continuity (1)
Related Publication 20180353180A1 · Dec 13, 2018
Cited By (6)
US 1,072,250 US 1,084,333 US 12,274,437 US 12,446,874 US 12,458,345 US 12,539,115